chart courtesy of

Industry: MED - DRUGS Closing Price: $19.90 P/E: 12.59 Avg.Vol.: 13473K

Company Profile: Bristol-Myers Squibb Company engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of pharmaceuticals and nutritional products worldwide. It operates in two segments, Pharmaceuticals and Nutritionals. The Pharmaceuticals segment offers cardiovascular products, virology products, oncology products and other psychiatric disorder products. It sells its pharmaceutical products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, and pharmacies. The Nutritionals segment manufactures, markets, distributes, and sells infant formulas and other nutritional products comprising ENFAMIL products that contain nutrients. The company is also developing various compounds, which are in phase III clinical trials.

Objective: While looking for BMY to trade near its recent range, we will use an Income Stragegy with consideration for additional Accumulated Income.

Trade: BUY the SEP 20 CALLS and SELL the JUN 20 CALLS (Calendar Spread) for a Debit of at or near .70

Entry Target: BMY between 19.50 and 20.50 with Initial RISK MANAGEMENT Alerts at 19.20 and 20.80